Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine

Journal of Hepatology

Volumn 33, Issue 3, 2000, Pages 371-375

  Richardson, Paul D ^a   James, Peter D ^a   Ryder, Stephen D ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Immunomodulation; Mycopenoloic acid; Therapy

Indexed keywords

AZATHIOPRINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; MAINTENANCE THERAPY; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; REMISSION; VOMITING;

EID: 0033845138     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80271-8     Document Type: Article

References (31)

1. Natural history of active chronic hepatitis, clinical features, course, diagnostic criteria mortality and survival
2. Autoimmunity and liver disease
3. Chronic active hepatitis: The spectrum of disease
4. High prevelence of seroimmunological markers in relatives of patients with active chronic hepatitis or primary biliary cirrhosis
5. Immunogenetic studies of autoimmune hepatitis, HLA, immunoglobulin allotypes, and autoantibodies
6. Autoimmune features in patients with chronic active hepatitis who are seronegative for conventional autoantibodies
7. Effects of prednisolone on the survival of patients with cirrhosis of the liver
8. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis
9. Clinical biochemical and histological remission in severe chronic active liver disease: A controlled study of treatment and early prognosis
10. Controlled trial of prednisolone and azathioprine in active chronic hepatitis
11. Maintenance of remission in patients with autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal
12. Azathioprine for long-term maintenance of remission in autoimmune hepatitis
13. Relapse following azathioprine withdrawal in patients with autoimmune chronic active hepatitis
14. Oral budesonide for treatment of autoimmune chronic active hepatitis
15. The successful treatment of autoimmune hepatitis with 6-mercaptopurine after failure with azathioprine
16. Cyclosporin in the management of corticosteroid resistant type 1 autoimmune chronic active hepatitis
17. Tacrolimus: A potential new treatment for autoimmune chronic active hepatitis: Results of an open-label preliminary trial
18. Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis - Report of three cases
19. Successful treatment of therapy-refractory autoimmune hepatitis with mycophenolate mofetil
20. Mycophenoloic acid: An antibiotic from Penicillium brevicompactum Dierckx
21. Mycophenolate mofetil
22. Mycophenoloic acid for psoriasis
23. Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide
24. Therapy of rheumatoid arthritis with mycophenolate mofetil
25. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection
26. Mycophenolate mofetil vs azathioprine immunosuppressive regimens after lung transplantation
27. A blinded, long-term randomised multicentre study of mycophenolate mofetil in cadaveric renal transplantation: Resuits at 3 years
28. A randomised active-controlled trial of mycophenolate mofetil in heart transplant recipients
29. Incidence of leukopenia and CMV disease in kidney transplants treated with mycophenolate mofetil combined with low dose cyclosporin and steroid dose
30. Infectious complications occuring in liver transplant recipients receiving mycophenolate mofetil
31. Meeting report: International Autoimmune Hepatitis Group